<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1-276-96
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1996
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZANTAC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RANITIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        49.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXO SAUDI ARABIA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1182]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Zantac belongs to a group of medicines called H<sub>2</sub>-receptor blockers. It works by reducing the amount of acid in your stomach.</p><p>Adults</p><p><strong>Zantac is used to:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heal ulcers in the stomach, or the part that it empties into (<em>the duodenum</em>). In some cases, Zantac may be given with antibiotics (medicines used to treat infection).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prevent stomach ulcers which may be caused by medicines called non-steroidal anti-inflammatory drugs (NSAIDs), often used to treat arthritis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prevent ulcers from bleeding</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heal or stop problems caused by acid in the food pipe (<em>oesophagus</em>) or too much acid in the stomach. This can cause pain or discomfort sometimes known as indigestion or heartburn</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stop acid coming up from the stomach while under anaesthetic during an operation.</p><p><strong><em>Children (aged 1 month to 11 years)</em></strong></p><p><strong>Zantac is used to:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heal ulcers in the stomach, or the part that it empties into (<em>the duodenum</em>)</p><p>heal or stop problems caused by acid in the food pipe (<em>oesophagus</em>) or too much acid in the stomach. This can cause pain or discomfort sometimes known as indigestion or heartburn.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Don&rsquo;t take Zantac &nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>allergic</strong> (<em>hypersensitive</em>) to ranitidine or any other ingredients of Zantac (listed in Section 6).</p><p>&egrave;<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>If you think this applies to you,<strong> don&rsquo;t take Zantac</strong> until you have checked with your doctor.</p><p>Take special care with Zantac</p><p>&nbsp;</p><p>Before you take Zantac your doctor needs to know:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>stomach cancer</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>kidney disease,</strong> your doctor may lower your dose of Zantac</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a rare condition called <strong>acute porphyria</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>over 65 years old</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>lung disease</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>diabetic</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have any <strong>problems with your immune system</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have had <strong>stomach ulcers</strong> before and you <strong>are taking Non-Steroidal Anti-Inflammatory (NSAID) medicines</strong>.</p><p>&nbsp;</p><p>&egrave; <strong>Check with your doctor </strong>if you think any of these may apply to you<strong>. </strong></p><p><strong>&nbsp;</strong></p><p>Other medicines and Zantac</p><p><strong>Tell your doctor or pharmacist if you&#39;re taking any other medicines</strong>, if you&rsquo;ve taken any recently, or if you start taking new ones. This includes medicines bought without a prescription.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Some medicines can affect how Zantac works, or make it more likely that you&rsquo;ll have side effects. Zantac can also affect how some other medicines work. These include:</p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; procainamide or n-acetylprocainamide (used to treat <strong>heart problems</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; warfarin (used to <strong>thin the blood</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; triazolam (used to treat <strong>insomnia</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glipizide (used to <strong>lower blood glucose</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; midazolam (a <strong>sedative</strong> that may be given just <strong>before an operation</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ketoconazole (used to treat <strong>fungal infections</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; atazanavir or delaviridine (used to treat <strong>HIV</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gefitinib (used to treat <strong>lung cancer</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Steroidal Anti-Inflammatory (NSAID) medicines (used to treat <strong>pain</strong> and <strong>inflammation</strong>).</p><p>&egrave;&nbsp;&nbsp;&nbsp; <strong>Tell your doctor or pharmacist</strong> if you are taking any of these.</p><p>&nbsp;</p><p>Pregnancy and breast-feeding</p><p>If you are<strong> pregnant</strong>, or <strong>think you could be, </strong>or if you are <strong>planning to become pregnant</strong>, <strong>don&rsquo;t take Zantac</strong> without checking with your doctor. <strong>&nbsp;Your doctor </strong>will consider the risks and benefits to you and your baby<strong> </strong>of taking Zantac.</p><p>&nbsp;</p><p>The ingredients in Zantac can pass into breast milk.&nbsp; <strong>If you are breast-feeding, you must check with your doctor</strong> before you take Zantac.</p><p><strong>&nbsp;</strong></p><p><strong>Effects on ability to drive and use machines</strong></p><p>None reported.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always take</strong><strong> Zantac exactly as your doctor has told you to.</strong> Check with your doctor or pharmacist if you&#39;re not sure.</p><p>&nbsp;</p><p>How much to take</p><p><strong><em>Adults</em></strong></p><p>The usual dose is either:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150 mg in the morning and 150 mg in the evening or,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300 mg at bedtime.</p><p>Your exact dose will depend on your particular stomach condition.&nbsp; Your doctor will tell you the dose you should take.</p><p><strong><em>Children (aged 1 month to 11 years)</em></strong></p><p>Your doctor will decide on the correct dose of Zantac for your child, depending on their weight.</p><p>&nbsp;</p><p>How to use</p><p>Swallow each tablet whole with some water.</p><p>If you forget to take Zantac &nbsp;</p><p>&nbsp;</p><p>If you forget a dose, take it as soon as you remember it, unless it is nearly time for your next dose.&nbsp; <strong>Don&#39;t take a double dose. </strong></p><p>&nbsp;</p><p>If you take too much Zantac</p><p>&nbsp;</p><p>If you take<em> </em>too much<em> </em>Zantac, <strong>contact your doctor or pharmacist for advice.</strong> If possible, show them the Zantac pack.</p><p>Don&rsquo;t stop Zantac without advice</p><p><strong>&nbsp;</strong></p><p><strong>It is important that you take the full course of Zantac</strong>. Don&rsquo;t stop too early, even if you begin to feel better. If you don&rsquo;t complete the full course, the treatment might not be effective and your symptoms may come back.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Zantac can cause side effects, but not everybody gets them.</p><p>Conditions you need to look out for</p><p>&nbsp;</p><p><strong>Severe allergic reaction: </strong>These are rare in people taking Zantac. Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; raised and itchy rash (<em>hives</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, sometimes of the face or mouth (<em>angioedema</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain, shortness of breath, unexplained fever, wheezing or difficulty in breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling faint, especially when standing up</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse.</p><p>&egrave;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Contact a doctor immediately </strong>if you get any of these symptoms. Stop taking Zantac.</p><p>&nbsp;</p><p><strong>Serious skin reactions: </strong>These are very rare in people taking Zantac. Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash, which may blister, and look like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge).</p><p>&egrave;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Contact a doctor immediately </strong>if you get any of these symptoms. Stop taking Zantac.</p><p><strong>Rare side effects</strong></p><p>These may affect <strong>up to 1 in 1,000 people</strong>:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash.</p><p>&nbsp;</p><p>Rare side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes to liver function.</p><p>Very rare side effects</p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of blood vessels (<em>vasculitis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the pancreas (<em>pancreatitis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver (<em>hepatitis</em>), sometimes with yellowing of the whites of the eyes or skin (<em>jaundice</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation in the kidney (<em>interstitial nephritis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slow or irregular heartbeat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling confused, depressed, or seeing or hearing things that are not really there (<em>hallucinations</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint or muscle pain, or uncontrolled movement</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache, dizziness, blurred vision</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unusual hair loss or thinning (<em>alopecia</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unable to get or maintain an erection (<em>impotence</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unusual secretion of breast milk or breast enlargement in men.</p><p>Very rare side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low levels of white blood cells</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in number of blood platelets (cells that help blood to clot)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in number of all types of blood cells.</p><p>&nbsp;</p><p>If you get side effects</p><p>&egrave; <strong>Tell your doctor or pharmacist</strong> if any of the side effects listed becomes <strong>severe or troublesome</strong>, or if you notice any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>&nbsp;</p><p>&nbsp;</p><p>Store below 30&deg;C Store in the original package to protect from moisture</p><p>&nbsp;</p><p>If you have any unwanted Zantac, don&rsquo;t dispose of it in your waste water or household rubbish.&nbsp; Ask your pharmacist how to dispose of medicines no longer required.&nbsp; This will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Zantac contains</p><p>&nbsp;</p><p>The active ingredient is ranitidine (as ranitidine hydrochloride).</p><p>Zantac tablets come in different strengths.</p><p>&nbsp;</p><p>Each tablet contains:</p><p>150 mg ranitidine hydrochloride.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The 150 mg film-coated tablets are packed either in foil strips or double foil blisters.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufactured and packed by:</p><p>Glaxo Saudi Arabia Ltd.*, Jeddah KSA.</p><p>&nbsp;</p><p>Marketing Authorisation Holder:</p><p>Glaxo Saudi Arabia Ltd.*, Jeddah KSA.</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia.</p><p>&nbsp;</p><p>*member of GlaxoSmithKline group of companies</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: GDS45
 Date of issue:  27 November 2017

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>زانتاك ينتمي إلى مجموعة من الأدوية تدعى حاصرات مستقبلات الهيستامين-H2. يعمل العقار عن طريق خفض كمية الحموضة في معدتك.</p><p>&nbsp;</p><p><strong>البالغين</strong></p><p><strong>يستخدم زانتاك في:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج قرحة المعدة، أو الجزء الذي تفرغ محتوياتها فيه (الإثنى عشر) . في بعض الحالات يعطى الزانتاك مع المضادات الحيوية (ادوية تستخدم لعلاج العدوى).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - منع الإصابة بقرح المعدية والتي قد يكون سببها الأدوية غير ستيرويدية مضادة للالتهاب تستخدم في الأغلب لعلاج التهاب المفاصل .</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وقاية التقرحات من النـزف.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج وإيقاف المشاكل التي سببها الحموضة في أنبوب الطعام (المريء) أو حموضة بكمية كبيرة في المعدة. فهذا قد يسبب ألم وعدم الشعور بالراحة في بعض الأوقات وهو ما يعرف بعسر الهضم أو حرقة المعدة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إيقاف ارتداد الحموضة من المعدة بينما تكون تحت التخدير أثناء الجراحة.</p><p>&nbsp;</p><p><strong>الأطفال (من سن شهر إلى 11 عاماً):</strong></p><p><strong>يستخدم زانتاك في:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج القرحة الهضمية، أو الجزء الذي تفرغ محتوياتها فيه (الإثنى عشر).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج وإيقاف المشاكل التي سببها الحموضة في أنبوب الطعام (المريء) أو حموضة بكمية كبيرة في المعدة. فهذا قد يسبب ألم وعدم الشعور بالراحة في بعض الأوقات وهو ما يعرف بعسر الهضم أو حرقة المعدة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تتناول زانتاك</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصاباً بحساسية (مفرط الحساسية) للرانيتيدين أو أي من المكونات الأخرى في زانتاك (مدرجة بالفقرة 6).</p><p>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تظن أن ما سبق ينطبق عليك، لا تستخدم زانتاك لحين مراجعة طبيبك.</p><p><strong>يجب توخي الحذر الشديد عند استعمال</strong> <strong>زانتاك</strong></p><p>قبل تناول زانتاك يحتاج طبيبك أن يعرف:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصاب بورم سرطاني بالمعدة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض بالكلى، قد يقرر طبيبك خفض جرعتك من زانتاك.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك حالة نادرة تدعى پُرْفيرِيَّة حادة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان عمرك يزيد عن 65 عاماً.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصاباً بمرض رئوي.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصاباً بداء السكري.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في جهاز المناعة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك قرحة في المعدة من قبل ومازلت تتناول الأدوية غير ستيرويدية مضادة للالتهاب</p><p>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp; <strong>يرجى مراجعة الطبيب</strong> إذا كنت تظن أن أي مما سبق ينطبق عليك.</p><p>&nbsp;</p><p><strong>إعطاء أدوية أخرى مع زانتاك.</strong></p><p>يرجى إبلاغ الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخراً أية أدوية أخرى، أو بدأت تناول أدوية جديدة. بما في ذلك الأدوية التي اشتريتها بدون وصفة طبية.</p><p>قد تؤثر الأدوية في بعض الأحيان على طريقة مزاولة زانتاك لمفعوله. أو تجعلك عرضة للإصابة بآثار جانبية. كما أن زانتاك قد يؤثر على طريقة مزاولة بعض الأدوية الأخرى لمفعولها. وهي تشمل:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﭘـروكاييناميد وN-أسيتيل ﭘـروكاييناميد (يستخدم لعلاج لمشاكل القلب).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وارفارين (يستخدم كمضاد لتخثر الدم).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تريازولام (يستخدم لعلاج الأرق)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جليـﭙـيزايد (يستخدم لخفض سكر الدم).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميدازولام (مهديء قد يُعطى قبل إجراء العملية مباشرة).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كيتوكونازول (يستخدم لعلاج العدوى الفطرية).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أتازاناﭬـير أو ديلاﭬـيريدين (يستخدم لعلاج مرض نقص المناعة).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جيفيتينيب (يستخدم لعلاج سرطان الرئة).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية غير ستيرويدية مضادة للالتهاب (يستخدم لعلاج الألم و الالتهاب)</p><p>&nbsp;</p><p>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اخبر طبيبك أو الصيدلي</strong> إذا كنت تتناول أي منها.</p><p>&nbsp;</p><p><strong>الحمل والرضاعة الطبيعية</strong></p><p>إذا كنتِ حامل، أو تظنين أنكِ حامل، أو تخططين للحمل، لا تستخدمين زانتاك بدون مراجعة طبيبك. سوف يأخذ <strong>طبيبك</strong> في الإعتبار المخاطر والفوائد لك ولطفلك نتيجة تناول زانتاك.</p><p>المكونات الموجودة في زانتاك يمكن أن تنتقل إلى حليب الأم. <strong>إذا كنتِ تقومين بالرضاعة الطبيعية، يجب مراجعة طبيبك</strong> قبل تناول زانتاك.</p><p><strong>التأثير على القدرة على القيادة</strong><strong> </strong><strong>واستخدام</strong><strong> </strong><strong>الآلات</strong></p><p>لم يرد ذكر أية تأثيرات لزانتاك على القدرة على قيادة السيارات أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>تناول زانتاك كما وصفه لك الطبيب دائماً، استشر الطبيب أو الصيدلي إذا لم تكن متأكداً </strong></p><p><strong>&nbsp;</strong></p><p><strong>الكمية الواجب تناولها</strong></p><p><strong><em>البالغين</em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150 ملجم في الصباح و 150 ملجم في المساء او,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300 ملجم في وقت النوم.</p><p>جرعتك سوف تحدد بناءا على حالة معدتك , طبيبك سيحدد لك الجرعة .</p><p><strong><em>الأطفال (من سن شهر إلى 11 عاماً)</em></strong></p><p>الجرعة الصحيحة سيقررها طبيبك لطفلك ,بناءا على وزنه.</p><p><strong>كيفية الاستخدام</strong></p><p>ابتلاع القرص بالكامل مع بعض لماء.</p><p><strong>إذا نسيت تناول زانتاك أقراص </strong></p><p>إذا فاتك تناول جرعة يجب تناول زانتاك أقراص في أسرع وقت ممكن الا اذا اقترب وقت الجرعة القادمة.</p><p>لا يجوز تناول جرعة مضاعفة.</p><p><strong>إذا تناولت أكثر مما يجب تناوله من زانتاك أقراص </strong></p><p>إذا تناولت أكثر مما يجب تناوله من الأقراص، <strong>يرجى</strong><strong> </strong><strong>مراجعة</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>للاستشارة. </strong>اذا امكن اعرض لهم علبة الزانتاك.</p><p><strong>لا تتوقف عن تناول زانتاك بدون استشارة الطبيب . </strong></p><p>&nbsp;من المهم مواصلة تناول زانتاك حتى انتهاء العلاج، لا تتوقف قبل الموعد المحدد,حتى إذا شعرت بتحسن. ان لم تكمل الفترة المحددة لك كاملة , قد يكون العلاج غير فعال و عودة الأعراض مرة أخرى</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كشأن كافة الأدوية، زانتاك قد يسبب آثاراً جانبية، إلا أنها لا تصيب كل فرد.</p><p><strong>حالات يجب توخي الحذر معها</strong></p><p><strong>ردود فعل تحسسية شديدة:</strong> يحدث لعدد نادر من الأفراد الذين يتناولون زانتاك. الأعراض تتضمن:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مرتفع مصحوب بحكة (شرى)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم، بعض الأحيان في الوجه أو الفم (وذمة وعائية).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر، ضيق في النفس، حُمى غير مبررة، أزيز أو صعوبة في التنفس.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالوهن، خاصة عند الوقوف.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنهيار.</p><p><strong>&not;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يجب الاتصال بالطبيب على الفور</strong> في حالة الإصابة بأي من هذه الأعراض، يجب وقف تناول زانتاك.</p><p><strong>ردود فعل خطيرة في جلد:</strong> يحدث لعدد نادر جداً من الأفراد الذين يتناولون زانتاك. الأعراض تتضمن:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي، قد يُكَوِّن فقاعات، أو يكون على هيئة أهداف صغيرة (بقعة داكنة مركزية محاطة بمنطقة أفتح، مع حلقة داكنة حول الحافة)</p><p><strong>&not;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يجب الاتصال بالطبيب على الفور</strong> في حالة الإصابة بأي من هذه الأعراض، يجب وقف تناول زانتاك.</p><p>&nbsp;</p><p><strong>آثار جانبية نادرة</strong></p><p>قد تصيب <strong>حتى فرداً واحداً من كل 1000 فرد</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود فعل تحسسية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي.</p><p>ردود فعل نادرة قد تظهر في تحاليل الدم:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات بنتائج اختبارات وظائف الكبد.</p><p>&nbsp;</p><p><strong>آثار جانبية نادرة جداً</strong></p><p>قد تصيب <strong>حتى فرداً واحداً من كل 10000 فرد</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب كبدي، مصحوب أحياناً باصفرار بياض العينين أو الجلد (يرقان).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب في الكلي (التهاب الكلي الخلوي).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تباطؤ أو اضطراب ضربات القلب.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إحساس بالإرتباك، الإكتئاب، أو ورؤية أو سماع أشياء غير موجودة بالفعل (هلوسة).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم مفصلي أو عضلي، أو حركة لاإرادية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع، دوخة، رؤية غير واضحة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان أو ترقق في الشعر غير طبيعي (صلع).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة أو الحفاظ على الانتصاب (عُنَّة).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تدفق حليب أو تضخم غير طبيعي في الثدي لدى الرجال.</p><p>ردود فعل نادرة جداً قد تظهر في تحاليل الدم:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات خلايا الدم البيضاء.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفيحات الدموية (خلايا تساعد الدم على التخثر).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد جميع أنواع خلايا الدم.</p><p>&nbsp;</p><p>إذا أُصِبتَ بأي من الآثار الجانبية</p><p><strong>&not;&nbsp; </strong><strong>&nbsp;يرجى الاتصال بالطبيب أو الصيدلي</strong> إذا أصبحت أي من الآثار الجانبية <strong>خطيرة أو مزعجة</strong>، أو إذا لاحظت أية آثار جانبية غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>يحفظ بعيداً عن متناول ونظر الأطفال</strong>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يخزن زانتاك تحت 30<sup>&deg;</sup>م.</p><p>يحفظ في العبوة الأصلية لحمايته من الرطوبة</p><p>&nbsp;</p><p>إذا أخبرك الطبيب بوقف تناول زانتاك، فمن المهم إعادة أي كمية متبقية إلى الصيدلي.</p><p>إذا كان لديك أي كمية متبقية غير مستخدمة من زانتاك لا تتخلص منها في مياه الصرف الصحي أو المخلفات المنـزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد على وقاية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي <em>رانيتيدين</em><em> هيدروكلورايد</em></p><p><em>أقراص زانتاك تأتي بتركيزات مختلفة</em></p><p><em>كل قرص يحتوي :</em></p><p><em>150 ملجم رانيتيدين هيدروكلورايد</em></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            اقراص مكسوة بغلاف غشائي  150 ملجم معبأة في شرائط فضية أو شرائط فضية مزدوجة
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>تصنيع وتعبئة:</strong></p><p>جلاكسو العربية السعودية المحدودة* جدة، السعودية.</p><p><strong>الشركة المالكة لرخصة التسويق</strong></p><p>جلاكسو العربية السعودية المحدودة* جدة، السعودية.</p><p>العنوان: صندوق بريد22617، جدة 21416، المملكة العربية السعودية.</p><p>*عضو في مجموعة شركات جلاكسو سميث كلاين.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم الإصدار: GDS45
تاريخ الإصدار: 27 نوفمبر 2017

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZANTAC film-coated Tablet Ranitidine 150 mg 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zantac 150 mg tablets: Each tablet contains 150 mg ranitidine as hydrochloride salt.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li><strong><em>Adults/Adolescents (12 years and over)</em></strong></li></ul><p><strong><em>Oral formulations:</em></strong></p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prevention of non-steroidal anti-inflammatory drug (NSAID) (including aspirin) associated duodenal ulcers, especially in patients with a history of peptic ulcer disease.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Duodenal ulcer associated with Helicobacter pylori infection.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Post-operative ulcer.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reflux oesophagitis.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Symptom relief in gastro-oesophageal reflux disease.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Zollinger-Ellison Syndrome.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chronic episodic dyspepsia characterised by pain (epigastric or retrosternal) which is related to meals or disturbs sleep but not associated with the above conditions.&nbsp;</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of stress ulceration in seriously ill patients.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of recurrent haemorrhage from peptic ulcer.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of Mendelson&#39;s syndrome.</p><p><strong><em>Injection:</em></strong></p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Duodenal ulcer.</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benign gastric ulcer.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Post-operative ulcer.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reflux oesophagitis.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Zollinger-Ellison Syndrome.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of stress ulceration in seriously ill.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of recurrent haemorrhage from peptic ulcer.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of Mendelson&#39;s syndrome.</p><p><strong><em>&nbsp;</em></strong></p><ul><li><strong><em>Children/Infants (1 month to 11 years)</em></strong></li></ul><p><strong><em>Oral formulations:</em></strong></p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of peptic ulcer</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptom relief of gastro-oesophageal reflux disease</p><p><strong><em>Injection:</em></strong></p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of peptic ulcer</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptom relief of gastro-oesophageal reflux disease</p><p>&shy;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prophylaxis of stress ulceration in seriously ill-patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General Information: </strong></p><p><em>ZANTAC</em> effervescent tablets should be placed in half a glass of water (minimum 75&nbsp;ml) and allowed to dissolve completely before swallowing, swirl the glass if necessary. For 300&nbsp;mg doses a volume of 150&nbsp;ml is recommended.</p><p><em>ZANTAC</em> effervescent tablets contain aspartame.</p><p>Populations</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Adults /Adolescents (12 years and over)</em></strong></p><p><strong><em>Oral Formulations:</em></strong></p><p><strong>DUODENAL ULCER AND BENIGN GASTRIC ULCER</strong></p><p><strong>Acute treatment</strong></p><p>The standard dosage regimen for duodenal or benign gastric ulcer is 150&nbsp;mg twice daily or 300&nbsp;mg once nightly. In most cases of duodenal ulcer, or benign gastric ulcer, healing occurs within 4 weeks. Healing usually occurs after a further 4 weeks in those not fully healed after the initial 4 weeks.</p><p>In duodenal ulcer 300&nbsp;mg twice daily for 4 weeks results in healing rates which are higher than those at 4 weeks with ZANTAC 150&nbsp;mg twice daily or 300&nbsp;mg once nightly. The increased dose has not been associated with an increased incidence of unwanted effects.</p><p><strong>Long-term management</strong></p><p>For the long-term management of duodenal or benign gastric ulcer the usual dosage regimen is 150&nbsp;mg once nightly.</p><p>Smoking is associated with a higher rate of duodenal ulcer relapse, and such patients should be advised to stop smoking. In those who fail to comply with such advice a dose of 300&nbsp;mg once nightly provides additional therapeutic benefit over the 150&nbsp;mg dosage regimen.</p><p><strong>NSAID ASSOCIATED PEPTIC ULCERATION</strong></p><p><strong>Acute treatment</strong></p><p>In ulcers following non-steroidal anti-inflammatory drug therapy, or associated with continued non-steroidal anti-inflammatory drugs, 8 to 12 weeks treatment may be necessary with 150&nbsp;mg twice daily or 300&nbsp;mg once nightly.</p><p><strong>Prophylaxis</strong></p><p>For the prevention of non-steroidal anti-inflammatory drug associated duodenal ulcers <em>ZANTAC</em> 150&nbsp;mg twice daily may be given concomitantly with non-steroidal anti-inflammatory drug therapy.</p><p>DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI INFECTION</p><p>ZANTAC 300&nbsp;mg once nightly or 150&nbsp;mg twice daily may be given with oral amoxicillin 750&nbsp;mg 3 times daily and metronidazole 500&nbsp;mg 3 times daily for 2 weeks. Therapy with ZANTAC only should continue for a further 2 weeks. This dose regimen significantly reduces the frequency of duodenal ulcer recurrence.</p><p>Maintainance treatment at a reduced dosage of 150 mg at bedtime is recommended for patients who have responded to short term therapy, particularly those with a history of recurrent ulcer.</p><p><strong>POST-OPERATIVE ULCER</strong></p><p>The standard dosage regimen for post-operative ulcer is 150&nbsp;mg twice daily.</p><p>Most cases heal within 4 weeks. Those not fully healed after the initial 4 weeks usually do so after a further 4 weeks.</p><p><strong>GASTRO-OESOPHAGEAL REFLUX DISEASE</strong></p><p><strong>Acute treatment</strong></p><p>In reflux oesophagitis 150&nbsp;mg twice daily or 300&nbsp;mg once nightly is administered for up to a period of 8, or if necessary, 12 weeks.</p><p>In patients with moderate to severe oesophagitis, the dosage of ZANTAC may be increased to 150&nbsp;mg 4 times daily for up to 12 weeks.</p><p><strong>Long-term management </strong></p><p>For the long-term management of reflux oesophagitis the recommended adult oral dose is 150&nbsp;mg twice daily.</p><p><strong>Symptom relief </strong></p><p>For the relief of symptoms associated with oesophageal acid reflux, the recommended regimen is 150&nbsp;mg twice daily for 2 weeks. This regimen may be continued for a further 2 weeks in those patients in whom the initial response is inadequate.</p><p><strong>ZOLLINGER-ELLISON SYNDROME</strong></p><p>The initial dosage regimen for Zollinger-Ellison syndrome is 150&nbsp;mg three times daily, but this may be increased as necessary. Doses up to 6 g per day have been well tolerated.</p><p><strong>CHRONIC EPISODIC DYSPEPSIA</strong></p><p>The standard dosage regimen for patients with chronic episodic dyspepsia is 150&nbsp;mg twice daily for up to 6 weeks. Anyone not responding or relapsing shortly afterwards should be investigated.</p><p><strong>PROPHYLAXIS OF MENDELSON&#39;S SYNDROME</strong></p><p>150&nbsp;mg 2 hours before anaesthesia, and preferably 150&nbsp;mg the previous evening. Alternatively, the injection is also available. In obstetric patients in labour 150&nbsp;mg every 6&nbsp;hours, but if general anaesthesia is required it is recommended that a non-particulate antacid (e.g. sodium citrate) be given in addition.</p><p>In obstetric patient at commencement of labour, an oral dose of 150 mg may be given followed by 150 mg at six hourly intervals. It is recommended that since gastring empting and drug absorption are delayed during labour, any patient requiring antacid (e.g. sodium citrate) prior to induction of anaesthesia. The usual precautions to avoid acid aspiration should also be taken</p><p>Prophylaxis of haemorrhage from stress ulceration in seriously ill patients or prohpylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration</p><p>150&nbsp;mg twice daily may be substituted for the injection once oral feeding commences.</p><p><strong><em>Injection:</em></strong></p><p><em>ZANTAC</em> Injection may be given as:-</p><p>-&nbsp;&nbsp;&nbsp; a slow (over 2 minutes) intravenous (i.v.) injection of 50&nbsp;mg, diluted to a volume of 20&nbsp;ml, every 6 to 8&nbsp;hours.</p><p>-&nbsp;&nbsp;&nbsp; an intermittent i.v. infusion at 25&nbsp;mg/h for 2 hours, repeated at 6 to 8&nbsp;hour intervals.</p><p>-&nbsp;&nbsp;&nbsp; an intramuscular (i.m.) injection of 50&nbsp;mg every 6 to 8 hours.</p><p><strong>PROPHYLAXIS OF MENDELSON&#39;S SYNDROME</strong></p><p>For prophylaxis of Mendelson&#39;s syndrome 50&nbsp;mg by i.m. or slow i.v. injection 45 to 60 minutes before induction of general anaesthesia.</p><p>Prophylaxis of haemorrhage from stress ulceration in seriously ill patients or prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration</p><p>In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration<strong><em>,</em></strong> parenteral administration may be continued until oral feeding commences.&nbsp; Patients considered to be still at risk may then be treated with <em>ZANTAC</em> tablets 150&nbsp;mg twice daily.</p><p>In the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriously ill patients, a priming dose of 50&nbsp;mg as a slow i.v. injection followed by a continuous i.v. infusion of 0.125-0.250&nbsp;mg/kg/h may be preferred.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Children/Infants (1 month to 11 years) (see Pharmacokinetics, Special Patient Populations and Children/Infants)</p><p><strong><em>Oral formulations:</em></strong></p><p>PEPTIC ULCER</p><p><strong>Acute treatment</strong></p><p>The recommended oral dose for the treatment of peptic ulcer in children is 4 mg/kg/day to 8 mg/kg/day administered as two divided doses to a maximum of 300 mg ranitidine per day for duration of 4 weeks. For those patients with incomplete healing, another 4 weeks therapy is indicated, as healing usually occurs after eight weeks of treatment.</p><p><strong>GASTRO-OESOPHAGEAL REFLUX</strong></p><p>The recommended oral dose for the treatment of gastro-oesophageal reflux in children is 5 mg/kg/day to 10 mg/kg/day administered as two divided doses to maximum of 600 mg<em> </em>(the maximum dose is likely to apply to heavier children or adolescents with sever symtoms).</p><p>&nbsp;</p><p><strong><em>&nbsp;Injection:</em></strong></p><p>Limited data exist on the administration of i.v ranitidine to children. ZANTAC Injection may be given as a slow (over 2 min) i.v. injection, up to a maximum of 50&nbsp;mg every 6 to 8 hours. This recommendation is derived from adult clinical studies and pharmacokinetic data in paediatric patients.</p><p><strong>PEPTIC ULCER acute treatment AND GASTRO-OESOPHAGEAL REFLUX</strong></p><p>Intranvenous therapy in children with peptic ulcer disease is indicated only when oral therapyis not possible.</p><p>For acute treatment of peptic ulcer disease and gastro-oesophageal reflux in paediatric patients, Zantac injection may be administered at doses that have been shown to be effective for disease in adults and effective for acid suppression in critically ill children. The intial dose (2.0 mg/kg or&nbsp; 2.5 mg/kg, maximum 50 mg) may be administered as slow intravenous infusion over 10 minutes, either with a syringe pump followed by a 3 mL flush with normal over saline over 5 min, or following dilution with normal saline 20 mL. Maintaenace of PH &gt; 4.0 can be achieved by intermitant infusion of 1.5 mg/kg every 6 h to 8 h. &nbsp;Alternatively treatment can be continuous, administrating loading dose of 0.45 mg/kg followed by continuous infusion of 0.15 mg/kg/hr.</p><p><strong>&nbsp;</strong></p><p><strong>PROPHYLAXIS OF STRESS ULCERATION IN SERIOUSLY ILL PATIENTS</strong></p><p><strong><em>&nbsp;</em></strong></p><p>The recommended dose for prophylaxis of stress ulceration is 1 mg/kg (maximum 50 mg) every 6 to 8 h.</p><p>Alternatively treatment can be continuous, administering 125-250 micrograms/kg/hr as contiuous infusion.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Neonates (under 1 month) (see Pharmacokinetics, Special Patient Populations, Neonates)</em></strong></p><p>Safety and efficacy in neonates has not been established.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Patients over 50 years of age </em></strong></p><p>(See Pharmacokinetics, Special Patient Populations and Patients over 50 years of age)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Renal Impairment</strong></p><p>Accumulation of ranitidine with resulting elevated plasma concentrations will occur in patients with renal impairment (creatinine clearance less than 50&nbsp;ml/min). Accordingly, it is recommended that the daily dose of oral rantidine in such patients should be 150 mg at night for 4-8 weeks. The same dose should be used for maintenance treatment, if nessesary. If an ulcer has not healed after treatment, 150 mg twice daily dosage should be instituted followed, if need be, by maintenance treatment of 150 mg at night.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZANTAC products are contraindicated in patients known to have hypersensitivity to any component of the preparation.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The possibility of malignancy should be excluded before commencement of therapy in patients with gastric ulcer and patients of middle age and over with new or recently changed dyspeptic symptoms, as treatment with <em>ZANTAC</em> may mask symptoms of gastric carcinoma.</p><p>Ranitidine is excreted via the kidney and so plasma levels of the drug are increased in patients with renal impairment.</p><p>The dosage should be adjusted as detailed above under Dosage and Administration in Renal Impairment.</p><p>Rare clinical reports suggest that ranitidine may precipitate acute porphyric attacks. <em>ZANTAC </em>should therefore be avoided in patients with a history of acute porphyria.</p><p>Although clinical reports of acute intermittent porphyria associated with rantidine administration have been rare and</p><p>inconclusive, rantidine should be avoided in patients with a history of this condition.</p><p>Regular supervision of patients who are taking non-steroidal anti-inflammatory drugs concomitantly with oral ZANTAC</p><p>is recommended, especially in the elderly and in those with a history of peptic ulcer.</p><p>In patients such as the elderly, persons with chronic lung disease, diabetes or the immunocompromised, there may be</p><p>an increased risk of developing community acquired pneumonia. A large epidemiological study showed an increased</p><p>risk of developing community acquired pneumonia in current users of H2 receptor antagonists versus those who had</p><p>stopped treatment, with an observed adjusted relative risk increase of 1.63 (95% CI, 1.07 - 2.48).</p><p>As ZANTAC effervescent tablets contain aspartame they should be used with caution in patients with</p><p>phenylketonuria. ZANTAC effervescent tablets contain sodium (see List of Excipients for sodium content). Care should</p><p>therefore be taken in treating patients in whom sodium restriction is indicated.</p><p>Bradycardia in association with rapid administration of ZANTAC injection has been reported rarely, usually in patients</p><p>with factors predisposing to cardiac rhythm disturbances. Recommended rates of administration should not be exceeded.</p><p>The use of higher than recommended doses of i.v. H2- antagonists has</p><p>been associated with rises in liver enzymes when treatment has been</p><p>extended beyond five days.</p><p>Treatment with a histamine H2-antagonist may mask symptoms</p><p>associated with carcinoma of the stomach and may therefore delay the</p><p>diagnosis of the condition. Accordingly, where gastric ulcer has been</p><p>diagnosed or in patient of middle age and over with new or recently</p><p>changed dyspeptic symptoms the possibility of malignancy shoulb be</p><p>excluded before therapy with ZANTAC tablets is instituted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine has the potential to affect the absorption, metabolism or renal excretion of other drugs.&nbsp; The altered pharmacokinetics may necessitate dosage adjustment of the affected drug or discontinuation of treatment.</p><p>&nbsp;</p><p>Interactions occur by several mechanisms including:</p><p>&nbsp;</p><p>1) Inhibition of cytochrome P450-linked mixed function oxygenase system:</p><p>Ranitidine at usual therapeutic doses does not potentiate the actions of drugs which are inactivated by this enzyme system such as diazepam, lidocaine, phenytoin, propranolol and theophylline.&nbsp;</p><p>There have been reports of altered prothrombin time with coumarin anticoagulants (e.g. warfarin). Due to the narrow therapeutic index, close monitoring of increased or decreased prothrombin time is recommended during concurrent treatment with ranitidine.</p><p>&nbsp;</p><p>2) Competition for renal tubular secretion:</p><p>Since ranitidine is partially eliminated by the cationic system, it may affect the clearance of other drugs eliminated by this route.&nbsp; High doses of ranitidine (e.g such as those used in the treatment of Zollinger-Ellison syndrome) may reduce the excretion of procainamide and N-acetylprocainamide resulting in increased plasma levels of these drugs.</p><p>&nbsp;</p><p>3) Alteration of gastric pH:</p><p>The bioavailability of certain drugs may be affected.&nbsp; This can result in either an increase in absorption (e.g. triazolam, midazolam, glipizide) or a decrease in absorption (e.g. ketoconazole, atazanavir, delaviridine, gefitinib).</p><p>&nbsp;</p><p>There is no evidence of an interaction between oral ranitidine and amoxicillin and metronidazole.</p><p>If high doses (2&nbsp;g) of sucralfate are co-administered with oral ranitidine the absorption of the latter may be reduced. This effect is not seen if sucralfate is taken after an interval of 2 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Fertility</em></strong></p><p><strong><em>There are no data on the effects of ranitidine on human fertility. There were no effects on male and female fertility in animal studies (see Pre-Clinical Safety Data).</em></strong></p><p><strong><em>Pregnancy and lactation</em></strong></p><p>Ranitidine crosses the placenta and is excreted in breast milk. Like other drugs <em>ZANTAC </em>should only be used during pregnancy or during breast-feeding if considered essential.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following convention has been utilised for the classification of undesirable effects: very common (&ge; 1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1000), very rare (&lt;1/10,000). Adverse event frequencies have been estimated from spontaneous reports from post-marketing data.</p><p>Blood &amp; Lymphatic System Disorders</p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood count changes (leucopenia, thrombocytopenia). These are usually reversible. Agranulocytosis or pancytopenia, sometimes with marrow hypoplasia or marrow aplasia.</p><p><strong>Immune System Disorders </strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity reactions (urticaria, angioneurotic oedema, fever, bronchospasm, hypotension and chest pain).</p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anaphylactic shock</p><p>These events have been reported after a single dose.</p><p><strong>Psychiatric Disorders </strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible mental confusion, depression and hallucinations.</p><p>These have been reported predominantly in severely ill and elderly patients.</p><p><strong>Nervous System Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache (sometimes severe), dizziness and reversible involuntary movement disorders</p><p><strong>Eye Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible blurred vision.</p><p>There have been reports of blurred vision, which is suggestive of a change in accommodation.</p><p><strong>Cardiac Disorders</strong></p><p>Very Rare: &nbsp;&nbsp;&nbsp;&nbsp; As with other H2&nbsp;receptor antagonists bradycardia, A-V block&nbsp; and, with the injection only, asystole.</p><p><strong>Vascular Disorders </strong></p><p>Very Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vasculitis</p><p>Gastrointestinal Disorders</p><p>Very Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute pancreatitis, diarrhoea.</p><p>Uncommon: Abdominal pain, constipation, nausea (these symptoms mostly improved during continuous treatment).</p><p><strong>Hepatobiliary Disorders </strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transient and reversible changes in liver function tests.</p><p>Very Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis (hepatocellular, hepatocanalicular or mixed) with or without jaundice, these were usually reversible.</p><p><strong>Skin and Subcutaneous Tissue Disorders </strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash.</p><p>Very Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erythema multiforme, alopecia.</p><p><strong>Musculoskeletal and Connective Tissue Disorders </strong></p><p>Very Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Musculoskeletal symptoms such as arthralgia and myalgia.</p><p><strong>Renal and Urinary Disorders </strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute interstitial nephritis.</p><p><strong>Reproductive System and Breast Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible impotence, breast symptoms and breast conditions&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (such as gynaecomastia and galactorrhoea)</p><p>The safety of rantidine has been assessed in children aged 0 to 16 years with acid &ndash; related disease and was generally well tolerated with an adverse event profile resembling that in adults. There are limited long term safety data available, in particular regarding growth and development.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine is very specific in action and no particular problems are expected following overdose with <em>ZANTAC </em>formulations. Symptomatic and supportive therapy should be given as appropriate.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine has a relatively long duration of action and so a single 150&nbsp;mg oral dose effectively suppresses gastric acid secretion for 12 hours.</p><p>Clinical evidence has shown that oral ranitidine combined with amoxicillin and metronidazole eradicates Helicobacter pylori in approximately 90% of patients. This combination therapy has been shown to significantly reduce duodenal ulcer recurrence. Helicobacter pylori infects about 95% of patients with duodenal ulcer and 80% of patients with gastric ulcer.</p><p>Mechanism of Action</p><p>Ranitidine is a specific, rapidly acting histamine H<sub>2</sub>-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Following oral administration of 150 mg ranitidine, maximum plasma concentrations (300 to 550 ng/mL) occurred after 1-3 hours. Two distinct peaks or a plateau in the absorption phase result from reabsorption of drug excreted into the intestine.&nbsp; The absolute bioavailability of ranitidine is 50-60%, and plasma concentrations increase proportionally with increasing dose up to 300&nbsp;mg.</p><p>Absorption of ranitidine after i.m. injection is rapid and peak plasma concentrations are usually achieved within 15 minutes of administration.</p><p>Distribution</p><p>Ranitidine is not extensively bound to plasma proteins (15%), but exhibits a large volume of distribution ranging from 96 to 142 L.</p><p>Metabolism</p><p>Ranitidine is not extensively metabolised. The fraction of the dose recovered as metabolites is similar after both oral and i.v. dosing; and includes 6% of the dose in urine as the N-oxide, 2% as the S-oxide, 2% as desmethylranitidine and 1 to 2% as the furoic acid analogue.</p><p>Elimination</p><p>Plasma concentrations decline bi-exponentially, with a terminal half-life of 2-3 hours.&nbsp; The major route of elimination is renal.&nbsp; After i.v. administration of 150&nbsp;mg 3H-ranitidine, 98% of the dose was recovered, including 5% in faeces and 93% in urine, of which 70% was unchanged parent drug.&nbsp; After oral administration of 150&nbsp;mg 3H-ranitidine, 96% of the dose was recovered, 26% in faeces and 70% in urine of which 35% was unchanged parent drug.&nbsp; Less than 3% of the dose is excreted in bile.&nbsp; Renal clearance is approximately 500 mL/min, which exceeds glomerular filtration indicating net renal tubular secretion.</p><p>Special Patient Populations</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Childen 3 years and above</p><p>Limited pharmacokinetic data show that there are no significant differences in half-life (range for children 3 years and above: 1.7 - 2.2 h) and plasma clearance (range for children 3years and above: 9 &ndash; 22 ml/min/kg) between children and healthy adults receiving oral ranitidine when correction is made for body weight).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Patients over 50 years of age</strong></p><p>In patients over 50 years of age, half-life is prolonged (3-4 hours) and clearance is reduced, consistent with the age-related decline of renal function.&nbsp; However, systemic exposure and accumulation are 50% higher.&nbsp; This difference exceeds the effect of declining renal function and indicates increased bioavailability in older patients.</p><p>Injection:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Neonates (under 1 month)</strong></p><p>Limited pharmacokinetic data suggests that plasma clearance of ranitidine may be reduced and half-life increased in neonates.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated-dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction and development.</em></strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:592px"><tbody><tr><td style="vertical-align:top"><p><strong><em>Tablets: </em></strong></p><p><strong><em>&nbsp;</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Injection: </em></strong></p><p><strong><em>&nbsp;</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Tablet core:</strong><br />Microcrystalline cellulose<br />Croscarmellose sodium (300&nbsp;mg tablet only)<br />Magnesium stearate</p><p><strong>Film coat:</strong><br />Opadry white OY-S-7322<br />Purified water<br />&nbsp;</p></td><td style="vertical-align:top"><p><strong>25&nbsp;mg/ml:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><br />Disodium hydrogen orthophosphate<br />Sodium Chloride<br />Potassium dihydrogen orthophosphate anhydrous<br />Water for injections<br />Nitrogen.</p><p><strong><em>&nbsp;</em></strong></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>ZANTAC </em>film-coated tablets<em> </em>should be stored below 30&deg;C.</p><p>Store in the original package to protect from moisture</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The tablets are packed either in foil strips or double foil blisters</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by:
Glaxo Saudi Arabia Ltd, Jeddah, Saudi Arabia
Marketing Authorisation Holder 
Glaxo Saudi Arabia Ltd.* Jeddah, KSA
Address: P.O. Box 22617 Jeddah 21416—Kingdom of Saudi Arabia 
*member of the GSK group of companies

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: GDS45/IPI11
Date of issue: 27 November 2017

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>